← back to search

John R. Hurst

AstraZeneca (Spain) · GB
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Physiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Asthma and respiratory diseases, and Cystic Fibrosis Research Advances.
h-index
76
citations
28,099
works
780
NIH funding
primary concept
Medicine
email

Recent publications

Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study
European Journal of Preventive Cardiology 2025cited by 22position: middledoi
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study
The Lancet Respiratory Medicine 2025cited by 14position: middledoi
Population-Based Screening for Chronic Obstructive Pulmonary Disease Using the St. George’s Respiratory Questionnaire in Resource-Limited Settings
American Journal of Respiratory and Critical Care Medicine 2025cited by 4position: middledoi
Implications of reference equations for interpretation of spirometry in three African countries: a cross-sectional study
ERJ Open Research 2025cited by 3position: middledoi
FEV <sub>1</sub> Q as a race-neutral assessment of lung function in Nepal, Peru and Uganda
European Respiratory Journal 2025cited by 1position: lastdoi
Lower Airway and Oral Microbiome Dysbiosis in Patients with Long COVID Post-Hospitalisation: A UK Multicentre, Prospective Cohort Study
SSRN Electronic Journal 2025cited by 0position: middledoi
Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment
Frontiers in Medicine 2024cited by 75position: middledoi
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)
American Journal of Respiratory and Critical Care Medicine 2024cited by 38position: middledoi
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A <i>Post Hoc</i> Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)
American Journal of Respiratory and Critical Care Medicine 2024cited by 28position: middledoi
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding
American Journal of Respiratory and Critical Care Medicine 2024cited by 24position: middledoi
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis
The Lancet Global Health 2024cited by 15position: middledoi
Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countries
Expert Review of Respiratory Medicine 2024cited by 15position: middledoi
Interdisciplinary perspectives on multimorbidity in Africa: Developing an expanded conceptual model
PLOS Global Public Health 2024cited by 10position: middledoi
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study – PHOSP-COVID
ERJ Open Research 2024cited by 9position: middledoi
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
ERJ Open Research 2024cited by 2position: middledoi
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
American Journal of Respiratory and Critical Care Medicine 2023cited by 73position: middledoi
Unravelling the respiratory health path across the lifespan for survivors of preterm birth
The Lancet Respiratory Medicine 2023cited by 60position: middledoi
Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group)
Respiratory Research 2023cited by 42position: middledoi
Unmet Diagnostic and Therapeutic Opportunities for Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Countries
American Journal of Respiratory and Critical Care Medicine 2023cited by 38position: lastdoi
QRISK3 underestimates the risk of cardiovascular events in patients with COPD
Thorax 2023cited by 28position: middledoi
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
The Lancet Regional Health - Europe 2023cited by 28position: middledoi
Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review
Frontiers in Immunology 2023cited by 23position: lastdoi
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
International Journal of Epidemiology 2023cited by 17position: middledoi
Chronic Obstructive Pulmonary Disease Self-Management in Three Low- and Middle-Income Countries: A Pilot Randomized Trial
American Journal of Respiratory and Critical Care Medicine 2023cited by 11position: middledoi
Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)
medRxiv 2023cited by 6position: middledoi
One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study
medRxiv 2023cited by 1position: middledoi
Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings
JAMA 2022cited by 69position: middledoi
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19
ERJ Open Research 2022cited by 25position: middledoi
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective
Advances in Therapy 2022cited by 16position: lastdoi
Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings
PLOS Global Public Health 2022cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Trishul Siddharthan · University of Miami10 papers (2018–2025) · 10 papers (2020–2025)Bruce Kirenga · Malaria Consortium9 papers (2021–2025)William Checkley · Johns Hopkins University9 papers (2020–2025) · 8 papers (2020–2025)Suzanne L. Pollard · Johns Hopkins University7 papers (2021–2025)Liam Smeeth · Qatar University7 papers (2012–2016)Alberto Papi · Instituto de Investigación Sanitaria de Santiago7 papers (2017–2023)Jennifer K Quint · Imperial College London6 papers (2014–2023) · 6 papers (2022–2025)Natalie A. Rykiel · Johns Hopkins Medicine6 papers (2022–2025)Jadwiga A. Wedzicha · Imperial College London6 papers (2017–2024)Nicole Robertson · Johns Hopkins University5 papers (2021–2025)Julie Barber · University of Idaho5 papers (2022–2025)Marc Miravitlles · Vall d'Hebron Institut de Recerca5 papers (2017–2021)Job F. M. van Boven · University of Colorado Denver5 papers (2018–2024)Adaeze C. Wosu · Johns Hopkins Medicine5 papers (2021–2024)Peter M.A. Calverley · University of Liverpool5 papers (2016–2018)Gerard J. Criner · Temple University Hospital5 papers (2017–2024)David Price · Virginia Tech4 papers (2017–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Physiology →